Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants by Munteanu, S, Nicolas Rocamora, E M, Martinez Perez, C, Bernabe Garcia, A, Nicolas Villaescusa, F J, Gimeno Blanes, J R, Arechavala Gomeza, V, Sabater Molina, M

Get full text

Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter? by Judez Serrano, A, Louchachha Medhi, S, Munteanu, S E M, Nicolas Rocamora, M E, Sabater Molina, M, Gimeno Blanes, J R

Get full text

Zebrafish dspb-/- mutant as model for arrhythmogenic cardiomyopathy - impact of physical activity by Munteanu, S, Wagih Gomez, J, Nicolas Rocamora, E M, Gil Ortuno, C, Bernabe Garcia, A, Judez Serrano, A, Martinez Perez, C, Gimeno Blanes, J R, Cayuela Fuentes, M L, Sabater Molina, M

Get full text

Zebrafish dspb -/- tert +/- mutant as model for arrhythmogenic cardiomyopathy. Impact of aging in the development of the disease by Wagih Gomez, J, Munteanu, S, Nicolas Rocamora, E, Gil Ortuno, C, Bernabe Garcia, A, Cayuela Fuentes, M L, Gimeno Blanes, J R, Sabater Molina, M

Get full text

144Trends in prevented sudden death in cardiomyopathies and channelopathies by Olmo Conesa, M C, Lopez Cuenca, D, Hernandez Del Rincon, J P, Pastor Quirante, F, Corral, R, Sabater Molina, M, Santos Mateo, J J, Perez Sanchez, I, Martin, J, Navarro Penalver, M, Munoz Esparza, C, Nicolas Rocamora, E, Gimeno Blanes, J R

Get full text